Paul Voziyan

Vanderbilt University Medical Center

Papers

1

Total Citations

116

H-Index

1

About

Paul Voziyan is a leading investigator in the pathogenesis of diabetic complications, with a primary focus on diabetic nephropathy (DN). His research has been instrumental in uncovering the molecular mechanisms driving kidney damage in diabetes, particularly through the lens of lipid metabolism and protein modification. In his highly cited 2014 work, which has garnered 116 citations, Voziyan demonstrated that DN induces significant, compartment-specific alterations in the lipid profiles of both glomeruli and tubules. This pivotal study highlighted how phospholipids and glycolipids—molecules critical for cell signaling and structure—become dysregulated in the diabetic kidney, offering new mechanistic insights into disease progression. Beyond this landmark paper, Voziyan is renowned for his extensive work on advanced glycation end-products (AGEs) and their role in diabetic tissue injury. His contributions have helped bridge the gap between basic biochemistry and clinical pathology, providing a foundation for novel therapeutic strategies aimed at preventing or slowing the devastating progression of diabetic kidney disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
116
Total Citations
116
Avg Citations/Paper
🏆 Most Cited Paper
Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles
116 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Vanderbilt University Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago